Mid Cap
Medical Devices
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Insulet
PODD
$9.92B
| $9.92B | $143.05 | 1.63% |
|
2
Bruker
BRKR
$8.66B
| $8.66B | $56.85 | 0.23% |
|
3
Haemonetics
HAE
$4.93B
| $4.93B | $108.32 | 0.07% |
|
4
LivaNova
LIVN
$4.37B
| $4.37B | $79.41 | 1.47% |
|
5
Integer Holdings
ITGR
$4.26B
| $4.26B | $125.39 | 0.26% |
|
6
iRhythm Holdings
IRTC
$4.06B
| $4.06B | $123.09 | 1.72% |
|
7
Transmedics
TMDX
$3.25B
| $3.25B | $93.60 | 0% |
|
8
Axogen
AXGN
$2.68B
| $2.68B | $49.93 | 1.42% |
|
9
Neogen
NEOG
$2.54B
| $2.54B | $11.64 | 0.34% |
|
10
Butterfly Network
BFLY
$2.41B
| $2.41B | $9.04 | 1.01% |
|
11
UFP Technologies
UFPT
$2.36B
| $2.36B | $304.21 | 0.39% |
|
|
ALMR
12
Alamar Biosciences
ALMR
$2.29B
| $2.29B | $33.02 | 0.98% |
|
13
Establishment Labs
ESTA
$2.15B
| $2.15B | $72.15 | 0.12% |
|
14
NovoCure
NVCR
$2.05B
| $2.05B | $17.62 | 5.13% |
|
Mid Cap Medical Devices Stocks at a Glance
Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.
There are 14 mid cap Medical Devices stocks — companies in the Medical Devices industry with a market cap between $2B and $10B — worth a combined $55.9B.
The largest by market cap are Insulet (PODD) at $9.92B, Bruker (BRKR) at $8.66B and Haemonetics (HAE) at $4.93B.
Among institutional investors, Alamar Biosciences (ALMR) drew the most net new fund positions in Q2 2026: 86 funds opened new positions.
- Combined market cap: $55.9B across 14 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Insulet (PODD), $9.92B market cap.
- Most net new fund positions in Q2 2026: Alamar Biosciences (ALMR), +86 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.